Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents

IMPORTANCE: The emergence of the B.1.617.2 (Delta) variant of SARS-CoV-2 has led to increases in both infections and hospitalizations among adolescents. Little is known about the effectiveness of the BNT162b2 vaccine in adolescents in the general population, as opposed to a clinical trial population...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Carlos R., Niccolai, Linda M., Sheikha, Hassan, Elmansy, Lina, Kalinich, Chaney C., Grubaugh, Nathan D., Shapiro, Eugene D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895259/
https://www.ncbi.nlm.nih.gov/pubmed/35238933
http://dx.doi.org/10.1001/jamanetworkopen.2022.0935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895259/
https://www.ncbi.nlm.nih.gov/pubmed/35238933
http://dx.doi.org/10.1001/jamanetworkopen.2022.0935

Ejemplares similares